GMP Compliance Consulting on Process Validation


Process Validation

Because end-product testing of biotechnological-derived products is of limited practicality, the validation of the manufacturing process is demanding regarding the complexity of biopharmaceuticals and immunotherapies.


Objective of Process Validation

The objective of process validation is to ensure product quality, in terms of safety and efficacy, and that products are being consistently produced and controlled to the quality standard appropriate to their intended use and as required by regulatory authorities for GMP release (21 CFR 211.100 and 21 CFR 211.110).

Audits and Inspections

Manufacturing of medicinal products is subject to inspections by regulatory authorities. The manufacturer is responsible to perform and implement process validation. The European Medicines Agency (EMA) and FDA represent Guidelines on Process Validation.

Process Equipment Qualification